title: [Madopar in the complex therapy of ischemic insult].
authors.forename: M M
authors.initials: MM
authors.lastname: Odinak
authors.forename: I A
authors.initials: IA
authors.lastname: Vozniuk
authors.forename: P A
authors.initials: PA
authors.lastname: Kovalenko
authors.forename: S V
authors.initials: SV
authors.lastname: Lobzin
authors.forename: S N
authors.initials: SN
authors.lastname: Ianishevskiĭ
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001545:Benserazide / Q000008:administration & dosage / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D002545:Brain Ischemia / Q000150:complications* / Q000503:physiopathology; D003071:Cognition / Q000187:drug effects; D015259:Dopamine Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004338:Drug Combinations; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D020521:Stroke / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D015259:Dopamine Agents; D004338:Drug Combinations; C005177:benserazide, levodopa drug combination; D007980:Levodopa; D001545:Benserazide